(For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for the Day Ahead newsletter, link.reuters.com/mex49s; for the Morning News Call newsletter, link.reuters.com/nex49s) U.S. stock index futures were higher on Thursday, a day after the Federal Reserve raised interest rates for the first time in almost a decade, signaling confidence in the strength of the world's largest economy. Dow Jones industrial average futures were up 0.22 percent at 17,774, S&P 500 futures were up 0.19 percent at 2,076 and Nasdaq 100 futures were up 0.37 percent at 4,680.25.
** KALOBIOS PHARMACEUTICALS INC, Wednesday close $23.59, -53.24 pct premarket
The FBI on Thursday arrested Martin Shkreli, the CEO of KaloBios and privately held Turing Pharmaceuticals, on securities fraud charges.
** AVON PRODUCTS INC, Wednesday close $4.09, +12.71 pct premarket
Private equity firm Cerberus Capital Management LP is close to an agreement to buy 80 percent of Avon’s North American business for $170 million, the Wall Street Journal reported on Thursday.
** FEDEX CORP, Wednesday close $148.83, +5.49 pct premarket
The package delivery company on Wednesday reported a better-than-expected quarterly net profit, saying higher margins, cost-cutting and a lower effective tax rate offset weak industrial production and global trade.
** GENERAL MILLS INC, Wednesday close $59.19, -2.01 pct premarket
General Mills’ quarterly sales fell 6 percent, the second straight quarter of decline, hurt by a strong dollar and weak demand for snacks and baking products in the United States, its biggest market.
** OCULUS INNOVATIVE SCIENCES INC, Wednesday close $1.1, +30.91 pct premarket
The skin and wound-care product maker said the FDA approved its new treatment for burning, itching, erythema, scaling and pain related to dandruff.
** GALAPAGOS NV, Wednesday close $58.9, +7.64 pct premarket
** GILEAD SCIENCES INC, Wednesday close $103.34, +0.54 pct premarket
Belgium’s Galapagos has signed a deal potentially worth more than $2 billion with U.S. firm Gilead to develop a drug targeting inflammatory diseases, reviving a project abandoned by former partner AbbVie.
** RITE AID CORP, Wednesday close $7.9, +1.39 pct premarket
The drugstore operator which has agreed to be bought by larger rival Walgreens Boots Alliance Inc, reported a 43 percent drop in quarterly profit, hurt by expenses related to its acquisition of pharmacy benefit manager EnvisionRx.
** GENERAL ELECTRIC CO, Wednesday close $30.98, -0.32 pct premarket
The company predicted on Wednesday a double-digit rise in operating earnings in 2016 to between $1.45 and $1.55 a share and said it would return about $26 billion to shareholders.
** ASTRAZENECA PLC, Wednesday close $33.79, -0.74 pct premarket
The company is to buy 55 percent of privately held biotech firm Acerta Pharma for $4 billion to give it access to a new kind of blood cancer drug, boosting its long-term growth at the cost of a near-term hit to earnings.
** DELTA AIR LINES INC, Wednesday close $52.12, -0.08 pct premarket
Delta said it expected a smaller fall in its passenger revenue per available seat mile (PRASM) for the December quarter.
** SHAW COMMUNICATIONS INC, Wednesday close $19.58, +0.10 pct premarket
Canada’s Shaw Communications said on Wednesday it has agreed to buy Wind Mobile, the country’s fourth-largest wireless provider, in a deal that gives it a much-needed presence in the cellular market.
** ELI LILLY & CO, Wednesday close $86.29, +0.16 pct premarket
The U.S. Food and Drug Administration on Wednesday approved Lilly’s diabetes drug Basaglar, a cheaper version of Sanofi AG’s SASY.PA top-selling drug Lantus.
** ORACLE CORP, Wednesday close $38.91, -0.72 pct premarket
The business software maker on Wednesday delivered a third-quarter profit forecast that did not quite meet analysts’ expectations, and the company’s shares fell about 1 percent in extended trading.
** AMERICAN INTERNATIONAL GROUP INC, Wednesday close $60.93, +0.94 pct premarket
AIG said on Wednesday that its board had authorized a $3 billion share repurchase plan.
** HALCON RESOURCES CORP, Wednesday close $0.321
The oil and gas producer on Wednesday announced a one-for-five reverse stock split, effective Jan. 5.
** ACCENTURE PLC, Wednesday close $109.08, -0.99 pct premarket
Accenture reported a 1.5 percent rise in quarterly revenue, helped by strong growth in its high-margin consulting business, particularly in North America. (Compiled by Natalie Grover in Bengaluru; Edited by Don Sebastian)